Blog: The Myriad gene patent case: its potential impact on the...
Recently, a federal appeals court heard oral arguments in a patent case, the ruling in which could significantly impact Massachusetts-based academic research organizations, biotechnology companies, and pharmaceutical companies.
Join the discussion below, or Read more at Mass High Tech.
#1 Aug 6, 2012
Does Mitt Romney/Bain Capital have financial interests in Utah diagnostic company Myriad Genetics?
#2 Aug 6, 2012
Seems as if someone should look into this. Do you have information on this matter? You seem to be suggesting such given your question.
Add your comments below
|Lower Availability of Omega-3 fatty Acids Assoc...||Nov 27||Nataly||1|
|$160B deal to combine Pfizer and Allergan raise...||Nov 26||Mite Be||21|
|CDC: 'Alarming' increase in STDs||Nov 25||Belles Echoes||123|
|Pfizer to buy Allergan in $160 billion deal||Nov 25||Cordwainer Trout||6|
|Press release distribution, EDGAR filing, XBRL,...||Nov 23||Buckle Up||1|
|Two murdered at Texas campsite are from Oceanside||Nov 19||James McMillan||1|
|US survey shows higher rate of autism in children||Nov 13||Vaccines Autism S...||1|
Find what you want!
Search Biotech Forum Now
Copyright © 2015 Topix LLC